Stay Informed on Corporate Sustainability

Author: REUTERS

Aug 27 (Reuters) - Amylyx Pharmaceuticals (AMLX.O), said on Wednesday it will stop development of its experimental drug for a rare brain disorder after it failed to improve symptoms in patients during a mid-stage trial.

Author: REUTERS

Indonesia will set a deadline of two years for food and beverage companies to meet new labelling norms for products high in salt, sugar or fat, a government official told Reuters, a move that spells more delays in efforts to curb fast-rising obesity.

Author: Pharmaphorum

Pharma commercialisation services provider EVERSANA (pharmaphorum's parent company) has acquired Waltz Health, a Chicago digital health company offering AI-driven marketplaces to lower overall drug costs. The terms of the deal were not disclosed.

Author: Pharmaphorum

It seems cardiologists are more optimistic than patients about the potential of AI in helping cardiac teams improve care and save lives.

Author: April Lara

Every initiative, from rigorous safety protocols to strategic advocacy and celebrated innovation, reflects a commitment to strengthen the sector’s foundation while embracing the opportunities ahead.

Author: April Lara

SGS strengthens pharmaceutical safety with advanced E&L testing, expert guidance, and global industry engagement.

Author: April Lara

The Pharma Industry Awards 2025 are set to shine a spotlight on the companies, teams, and projects that are driving Ireland’s pharmaceutical sector forward.

Author: Marubeni

Marubeni Corporation has completed its investment in Phillips Pharma, strengthening its pharmaceutical strategic platform across 26 countries and regions.

Author: Business Inquirer

The Department of Trade and Industry is partnering with AstraZeneca Philippines to establish a Pharma Innovation Hub aimed at driving healthcare innovation and expanding access to affordable medicines.

Author: Irish Independent

Novartis Ireland saw pre-tax profits fall 25 percent to €8.4 million in the last year as revenues declined 10 percent to €242.3 million, reflecting price and volume erosion of mature products.